Phoenix Financial Ltd. Grows Position in Danaher Corporation $DHR

Phoenix Financial Ltd. increased its position in shares of Danaher Corporation (NYSE:DHR) by 32.0% during the second quarter, HoldingsChannel reports. The institutional investor owned 8,602 shares of the conglomerate’s stock after buying an additional 2,083 shares during the quarter. Phoenix Financial Ltd.’s holdings in Danaher were worth $1,702,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds have also recently modified their holdings of DHR. GAMMA Investing LLC lifted its holdings in shares of Danaher by 22.2% during the first quarter. GAMMA Investing LLC now owns 9,126 shares of the conglomerate’s stock worth $1,871,000 after purchasing an additional 1,660 shares during the period. Pacific Capital Partners Ltd acquired a new stake in shares of Danaher during the first quarter worth $7,175,000. Flagship Harbor Advisors LLC lifted its holdings in shares of Danaher by 13.7% during the first quarter. Flagship Harbor Advisors LLC now owns 10,149 shares of the conglomerate’s stock worth $2,081,000 after purchasing an additional 1,221 shares during the period. Oppenheimer & Co. Inc. raised its stake in shares of Danaher by 9.2% during the 1st quarter. Oppenheimer & Co. Inc. now owns 25,096 shares of the conglomerate’s stock worth $5,145,000 after buying an additional 2,122 shares in the last quarter. Finally, Valmark Advisers Inc. raised its stake in shares of Danaher by 3.4% during the 1st quarter. Valmark Advisers Inc. now owns 2,365 shares of the conglomerate’s stock worth $485,000 after buying an additional 78 shares in the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities analysts have recently issued reports on DHR shares. Wall Street Zen raised Danaher from a “hold” rating to a “buy” rating in a research note on Friday, June 27th. Robert W. Baird raised their price objective on Danaher from $229.00 to $236.00 and gave the company an “outperform” rating in a research note on Wednesday, October 15th. Rothschild & Co Redburn reaffirmed a “neutral” rating and issued a $220.00 price objective (down from $245.00) on shares of Danaher in a research note on Wednesday, October 8th. Evercore ISI raised their price objective on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Finally, Scotiabank raised Danaher from a “sector perform” rating to a “sector outperform” rating and set a $275.00 price objective for the company in a research note on Friday, July 11th. Seventeen analysts have rated the stock with a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $245.00.

Insider Activity at Danaher

In other Danaher news, Director Teri List sold 2,778 shares of the business’s stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. The trade was a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.20% of the stock is currently owned by corporate insiders.

Danaher Price Performance

Shares of NYSE:DHR opened at $221.13 on Wednesday. The business’s fifty day moving average price is $202.07 and its two-hundred day moving average price is $197.59. The stock has a market cap of $158.34 billion, a PE ratio of 47.05, a price-to-earnings-growth ratio of 3.01 and a beta of 0.77. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.22 and a current ratio of 1.62. Danaher Corporation has a one year low of $171.00 and a one year high of $269.24.

Danaher (NYSE:DHR) last announced its earnings results on Tuesday, October 21st. The conglomerate reported $1.89 EPS for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The firm had revenue of $6.05 billion for the quarter, compared to analysts’ expectations of $6 billion. During the same quarter in the prior year, the firm earned $1.71 EPS. Danaher’s quarterly revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, analysts forecast that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be paid a dividend of $0.32 per share. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s payout ratio is currently 27.23%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.